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Abstract
Background: Neuron loss, glial activation and vascular degeneration are common sequelae of ischemia-reperfusion (I/R)
injury in ocular diseases. The present study was conducted to explore the ability of curcumin to inhibit retinal I/R injury, and
to investigate underlying mechanisms of the drug effects.
Methodology/Principal Findings: Different dosages of curcumin were administered. I/R injury was induced by elevating the
intraocular pressure for 60 min followed by reperfusion. Cell bodies, brn3a stained cells and TUNEL positive apoptotic cells
in the ganglion cell layer (GCL) were quantitated, and the number of degenerate capillaries was assessed. The activation of
glial cells was measured by the expression level of GFAP. Signaling pathways including IKK-IkBa, JAK-STAT1/3, ERK/MAPK
and the expression levels of b-tubulin III and MCP-1 were measured by western blot analysis. Pre-treatment using 0.01%–
0.25% curcumin in diets significantly inhibited I/R-induced cell loss in GCL. 0.05% curcumin pre-treatment inhibited I/R-
induced degeneration of retinal capillaries, TUNEL-positive apoptotic cell death in the GCL, brn3a stained cell loss, the I/R-
induced up-regulation of MCP-1, IKKa, p-IkBa and p-STAT3 (Tyr), and down-regulation of b-tubulin III. This dose showed no
effect on injury-induced GFAP overexpression. Moreover, 0.05% curcumin administered 2 days after the injury also showed
a vaso-protective effect.
Conclusions/Significance: Curcumin protects retinal neurons and microvessels against I/R injury. The beneficial effects of
curcumin on neurovascular degeneration may occur through its inhibitory effects on injury-induced activation of NF-kB and
STAT3, and on over-expression of MCP-1. Curcumin may therefore serve as a promising candidate for retinal ischemic
diseases.
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Introduction
Ischemia contributes to multiple ocular diseases, including
glaucoma and diabetic retinopathy [1]. Acute retinal ischemia
caused by high ocular pressure followed by reperfusion (I/R
injury) leads to neuronal and vascular degeneration, and to
inflammatory changes, including up-regulation of TNF-a, COX-2
and iNOS [2,3]. All of these abnormalities have also been found to
be elevated in rodent models of diabetic retinopathy [4,5,6,7], but
the changes in retinal I/R injury develop more rapidly and
severely. Investigators have used the rodent retinal I/R model to
study the mechanisms involved in the neurovascular degeneration
and to seek therapeutic ways to prevent this degeneration [2,3].
The mechanisms triggering retinal neurovascular degeneration
are not fully understood. Several pathways have been demon-
strated to play important roles in neuronal degeneration after I/R
injury, including glutamate excitotoxicity, oxidative and nitrative
stress, and inflammation [1]. Previous laboratory and proteomic
studies have demonstrated that aminoguanidine, an iNOS
inhibitor, inhibits retinal neurovascular degeneration following
I/R injury, seemingly via normalization of the expression levels of
glycolytic related enzymes [2,8,9]. Using CD40 knockout mice, we
demonstrated that the deficiency of CD40 gene inhibited I/R-
induced neurovascular degeneration, suggesting that the inflam-
matory and immune systems play critical roles in the development
of this I/R-induced retinal injury [3]. However, further studies on
the development of retinal neurovascular degeneration are needed
not only for better understanding of the pathogenesis of this
disease, but also for the discovery of novel therapeutic or
preventative methods.
Curcumin is a natural product extracted from turmeric (Curcuma
longa) that has been used for centuries in Asia to treat various
illnesses. Curcumin has been demonstrated to have beneficial
effects on rodent models of cancer, diabetes, cardiovascular
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mechanisms underlying these protective effects are based on
inhibitory actions of curcumin on disease-mediated induction of
inflammatory transcription factors, protein kinases, adhesion
molecules, oxidative stress and inflammation (see review of [11]).
The effects of curcumin on retinal diseases have been explored
recently. In streptozotocin-induced diabetic rats, curcumin
administration has been reported to inhibit a hyperglycemia-
induced reduction in antioxidant capacity, and to inhibit diabetes-
induced increases in retinal levels of IL-1b, VEGF and NF-kB
[12,13]. In a light-induced retinal degeneration model, curcumin
showed neuroprotective effects by inhibiting activation of NF-kB
and expression of inflammatory factors [14]. Effects of curcumin
on retinal I/R injury, especially on neurovascular degeneration,
have not been investigated. To address this, the effects of curcumin
on neuronal degeneration, vascular degeneration, glial cell
activation, and several signaling pathways/factors involved in
inflammatory responses have been evaluated after retinal I/R
injury. Our results suggest that curcumin has neuronal and
vascular protection effects, but shows no effect on glial activation
after retinal I/R injury.
Materials and Methods
Ethics Statement
Animal protocols were carried out with approval from the
Review Board for animal studies at the Wuhan University
(Approval Number #0200909) and according to the guidelines
of the Association for Research in Vision and Ophthalmology
Statement for the Use of Animals in Ophthalmic and Vision
Research, which are also approved by the Committee on Ethics in
the Care and Use of Laboratory Animals of Wuhan University.
Rat model of retinal ischemia-reperfusion
Male Wistar rats (200–300 g) were obtained from the Hubei
Animal Laboratory, and housed in ventilated microisolator cages
with free access to water and food. Retinal I/R injury was induced
as previously described [2,3]. Briefly, the anterior chamber of one
eye was cannulated with a 27-gauge needle attached to an infusion
line of normal saline. Pressure in the eye was increased to 80–
90 mmHg with a pressure infuser (Infu-surg, Ethox Corp., Buffalo,
NY). The other eye of the same animal served as the control. The
duration of ischemia was 60 min. After ischemia, the needle was
withdrawn, and reflow of the retinal circulation was documented
visually. Curcumin powder (Sinopharm Chemical Reagent Co.
Ltd., Shanghai, China) was first mixed with the powder form of
normal rodent chow in a food mixer for 2–3 hours, and then the
curcumin-containing chow was pelleted. Food pellets without
curcumin were used as the control diet. Curcumin (0.01%, 0.05%
and 0.25%, which are equivalent to 100, 500 and 2500 ppm in
diets) was administered to rats 2 days before the injury (for the
prevention studies). For another group of rats, 0.05% curcumin
was administered 2 days after the injury (for the intervention
studies). Animals were sacrificed at 12 hours to 7 days after I/R
injury for different analyses.
Isolation of retinal vasculature and quantitation of
degenerate capillaries
Eyes were isolated as previously described [2,4,6] and fixed with
10% neutral buffered formalin. Retinas were isolated, washed in
water overnight, and then incubated with 3% Difco crude trypsin
(BD BioSciences, Sparks, MD) at 37uC for 2 h. Non-vascular cells
were gently brushed away from the vasculature. The isolated
vasculature preparations were laid out on slides, and stained with
periodic acid-schiff and hematoxylin (PASH). Pictures were taken
on the middle and peripheral parts of retinal vascular tree for at
least 25 different fields per sample under 200X magnification.
Acellular (degenerate) capillaries identified as capillary-sized vessel
tubes (.30% diameter of regular capillary) that have no nuclei
anywhere along their length, were quantitated using the ImagePlus
6.0 software (Media Cybernetics, Bethesda, Maryland) and
reported per square millimeter of retinal area. 6–10 rats per
group were used for this analysis.
Examination of cell loss in ganglion cell layer
Enucleated eyes were routinely fixed in 10% buffered formalin,
embedded in paraffin, sectioned, and stained with PASH. High
resolution (6400 magnification) pictures of 6 different areas per
retina with about 340 mm retinal length per area (three continuous
pictures from each side of optic nerve head) were taken under an
Olympus BX60 microscope equipped with a digital CCD. The
nuclei in the ganglion cell layer (GCL; not including nuclei in the
vessels), which include ganglion cells and displaced amacrine cells
[15], were counted using the ImagePlus 6.0 software. 6–8 rats per
group were used for this analysis.
TUNEL assay
TUNEL assay (In Situ Cell Death Detection kit, fluorescein;
Roche, Mannheim, Germany) was performed to detect apoptotic
cell death on the paraffin-embedded retinal sections, as we
described previously [2]. TUNEL positive cells in the GCL, inner
nuclear layer (INL) and outer nuclear layer (ONL) were counted at
6 different areas per retinal section as described above, and
reported as number of TUNEL positive cells per millimeter of
retinal surface. 5–6 samples per group were used for this analysis.
Immunofluorescence staining
Paraffin-embedded sections were deparaffinized in xylene and
rehydrated in decreasing concentrations of ethanol. After blocking
with 2% goat serum, anti-b-tubulin III (1:500 dilution, Millipore,
Eschborn, Germany), anti-brn3a (1:50 dilution, Millipore, Es-
chborn, Germany) and GFAP (1:150 dilution, Millipore) antibod-
ies were applied on the sections for 1 h at room temperature. After
washing, the slides were then incubated with the respective
secondary antibodies for 1 h. After extensive washing with PBS,
sections were imaged by fluorescence microscopy. To measure the
brn3a stained cell loss, pictures were taken 6 different areas per
retinal section as described above, and brn3a stained cells were
counted. The result was reported as number of Brn3a stained cells
per millimeter of retinal surface. 4–6 samples per group were used
for brn3a and GFAP staining.
Western blot analysis
Retinas were isolated and sonicated in RIPA buffer (Beyotime
Biotech, China). Protein concentration was determined with the
BCA protein assay (Beyotime Biotech). 20–50 mg protein per
sample was separated by SDS-PAGE and electroblotted onto
PVDF membrane (Millipore), and membranes were then stained
with washable Ponceau S solution to confirm equal protein
loading. After washing, membranes were blocked in Tris-buffered
saline with 0.02% Tween 20 and 5% nonfat milk. Antibodies for
b-tubulin III (1:5000 dilution, Beyotime Biotech), GFAP (1:2000
dilution, Beyotime Biotech), IKKa (1:1000 dilution, CST,
Danvers, MA), IKKb (1:1000 dilution, CST), IKKc (1:400
dilution, Santa Cruz Biotechnology, Santa Cruz, CA), IkBa
(1:1000 dilution, CST), p-IkBa (1:500 dilution, Santa Cruz
Biotechnology), STAT3 (1:1000 dilution, CST), p-STAT3-Tyr
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STAT1 (1:1000 dilution, CST), p-STAT1 (1:1000 dilution, CST),
MCP-1 (1:500 dilution, Santa Cruz Biotechnology), ERK (1:5000
dilution, CST), p-ERK (1:1000 dilution, CST) and b-actin
(1:10000 dilution, Sigma, St. Louis, MO) were applied overnight
at 4uC. All blots were washed and incubated with respective
horseradish peroxidase coupled secondary antibodies (Bio-Rad) at
a dilution of 1:1000–1:10000. After extensive washing, protein
bands detected by the antibodies were visualized by ECL reagent
followed by exposure on X-OMAT film. The films were
subsequently scanned and band intensities were quantified using
the Quantity One 1-D Analysis Software (Bio-Rad). The protein
levels, except for the phosphorylated proteins, were first
quantitated relative to b-actin in the same sample, and then the
relative protein expression levels in different groups were
normalized to the non-injured group which set up as 1 fold.
Whereas the levels of the phosphorylated proteins were first
quantitated relative to their corresponding total protein levels in
the same sample, and then the relative phosphorylated protein
expression levels in different groups were normalized to the non-
injured group which set up as 1 fold. Each western blot analysis
was repeated 2–3 times with 3–5 samples in each group.
Statistical analysis
All results were expressed as the mean 6 SEM (stand error of
the mean). Data was analyzed by the nonparametric Kruskal-
Wallis test followed by the Mann-Whitney test. Differences were
considered statistically significant when the P,0.05.
Results
As we reported previously, retinal I/R injury induced a 5.6-fold
increase in formation of acellular (degenerate) capillaries in the
injured retinas compared to non-injured retinas 7 days after the
injury. Oral administration of 0.05% and 0.25% curcumin before
the I/R injury significantly inhibited I/R-induced vascular
Figure 1. Curcumin partially inhibited retinal I/R induced capillary degeneration. (A) Representative pictures of PASH stained retinal
vasculatures isolated from retinas 7 days after the I/R injury. Degenerate capillaries are indicated with black arrowheads. (B) Inhibition of retinal I/R-
induced capillary degeneration by curcumin. Group abbreviations are: C, non-injured eyes; I/R, I/R-injured retinas; I/R +0.01% Cur (BI), I/R-injured
retinas of animals treated with 0.01% curcumin 2 days before the injury; I/R +0.05% Cur (BI), I/R-injured eyes of animals treated with 0.05% curcumin 2
days before the injury; I/R +0.25% Cur (BI), I/R-injured eyes of animals treated with 0.25% curcumin 2 days before the injury; and I/R +0.05% Cur (AI), I/
R-injured eyes of animals treated with 0.05% curcumin 2 days after the injury. (n=6–10 rats per group; *P,0.001 compared with non-injured retinas;
**P,0.01 compared with I/R-injured retinas; ***P,0.05 compared with I/R-injured retinas. The error bars represent standard error of the mean. The
scale bar in Fig A represents 100 mm).
doi:10.1371/journal.pone.0023194.g001
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sections 2 days after the injury (100 mm length per picture). (B) Number of cells in the GCL was measured as described in Methods. Group
abbreviations are: C, non-injured eyes; I/R, I/R-injured eyes; I/R +0.01% Cur, I/R-injured eyes of animals treated with 0.01% curcumin 2 days before the
injury; I/R +0.05% Cur, I/R-injured eyes of animals treated with 0.05% curcumin 2 days before the injury; I/R +0.25% Cur, I/R-injured eyes of animals
treated with 0.25% curcumin 2 days before the injury. (n=6–8 rats per group; *P,0.001 compared with non-injured retinas; **P,0.005 compared
with I/R-injured retinas). The error bars represent standard error of the mean.
doi:10.1371/journal.pone.0023194.g002
Figure 3. Curcumin inhibited I/R induced apoptotic cell death of retinal neurons and down-regulation of b-tubulin III. (A)
Representative pictures of TUNEL assay on the retina sections 2 days after the injury. A TUNEL-positive retinal ganglion cell is indicated with white
arrowhead. Blue color: DAPI stained nuclei. Green color: TUNEL-positive cells. The scale bar represents 50 mm. (B) Quantitative results of TUNEL-
positive cells in the GCL. (n=4–5 different samples in each group, *P,0.01 compared with non-injured retinas; **P,0.05 compared with I/R-injured
retinas) The error bars represent standard error of the mean. (C-E) Curcumin rescued retinal I/R-induced down-regulation of b-tubulin III 2 days after I/
R injury. (C) Immunofluorescence staining of b-tubulin III on retinal sections. Blue color: DAPI stained nuclei. Green color: b-tubulin III staining. The
scale bar represents 50 mm. Representative western blots of b-tubulin III and b-actin in retinas (D) along with densitometric quantitative results (E)
(n=4 different samples in each group, *P,0.05 compared with non-injured retinas; **P,0.05 compared with I/R-injured retinas). The error bars
represent standard error of the mean. Group abbreviations are: C, non-injured eyes; I/R, I/R-injured eyes; I/R + Cur, I/R-injured eyes of animals treated
with 0.05% curcumin 2 days before the injury.
doi:10.1371/journal.pone.0023194.g003
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curcumin showed no significant protective effect on this lesion
(Figure 1). Oral administration of 0.05% curcumin 2 days after I/
R injury (when neuronal degeneration already was extensive) still
showed a significant vascular protective effect on the vasculature
(Figure 1).
Two days after retinal I/R injury, there was a significant cell
loss in the GCL, which is consistent with our previous observations
[2]. Oral administration of 0.01%, 0.05% and 0.25% curcumin all
significantly inhibited I/R-induced cell loss in GCL (Figure 2).
Inhibition of I/R-induced cell loss in GCL by curcumin in our
study did not show a dose-related effect, but neuronal cells were
protected at lower doses of curcumin than were vascular cells.
0.05% curcumin was selected for further studies since it was the
lowest dosage that showed both vascular and neuronal protective
effects on the injury.
Apoptosis contributes to retinal cell loss after retinal I/R injury.
TUNEL assay was performed to measure the apoptotic cell death
in retinal sections 2 days after the injury. Our results indicate that
I/R injury caused significant increases of TUNEL-positive cells in
the GCL, INL and ONL. 0.05% curcumin pre-treatment
inhibited retinal I/R induced apoptotic cell death in the GCL,
but not in the other two layers (Figure 3A and 3B).
There are ganglion cells and displaced amacrine cell in the
GCL, so the increased cell loss and TUNEL positive cells in the
GCL we observed may come from both cell types. To demonstrate
whether curcumin has effects on the retinal I/R induced ganglion
cell loss, two different methods were used. b-tubulin III has been
reported as a marker of retinal ganglion cells [16,17,18], and the
immunofluorescence staining also confirmed its cytoplasmic
localization in the GCL (Figure 3C). 0.05% curcumin showed
ganglion cell protective effects on retinal I/R injury, which was
demonstrated by evaluating the expression level of b-tubulin III 2
days after the injury using western blot. As shown in Figures 3D
and 3E, retinal I/R injury caused a 1.7-fold reduction on the
expression level of b-tubulin III, while curcumin pre-treatment
significantly inhibited this I/R-induced down-regulation. Brn3a is
a POU domain transcription factor that specifically expressed in
the nuclei of retinal ganglion cells [15,19]. As demonstrated in
Figure 4A, brn3a stained nuclei were exclusively located in the
GCL, which is consistent with previous reports [15,20], but only
some of the nuclei in the GCL were brn3a stained. Retinal I/R
injury induced a 4-fold reduction of brn3a stained cell in the GCL,
while curcumin pre-treatment mildly, but significantly inhibited
this I/R-induced ganglion cell loss (Figure 4B).
Glial cell activation is commonly found after retinal injury [21],
and the up-regulation of GFAP expression is one of the earliest
hallmarks of reactive gliosis [21]. As shown in Figure 5A, increased
expression of GFAP was found 12 hours after I/R injury, and this
upregulation lasted for at least 3 days. However, administration of
0.05% curcumin did not inhibit the injury-induced GFAP over-
expression at either 12, 24 or 48 hrs after the injury (Figure 5B,
data for 12 and 24 hrs not shown). Consistent with the western
blot results (Figure 5B), administration of 0.05% curcumin showed
no effect on the injury-induced GFAP over-expression of retinal
sections, which is mainly increased in activated muller cells after
the injury (Figure 5C).
Since inflammatory changes can contribute to neurovascular
degeneration after retinal I/R injury [2,8], we proposed that the
beneficial effects of curcumin on neurovascular degeneration was
due to its ability to inhibit these inflammatory responses. To test
this hypothesis, the signaling pathway that regulates activation of
NF-kB (a key transcription factor involved in the regulation of
inflammation) was investigated 2 days after the injury. Retinal I/R
injury induced significant increases in the expression levels of a
and b subunits of the IKK (IkB kinase) complex, but not the c
subunit (Figure 6). Our results demonstrated that oral adminis-
tration of 0.05% curcumin significantly inhibited the up-regulation
of IKKa, without affecting the expression level of IKKb, after I/R
injury (Figure 6). The levels of IkBaand p-IkBa were also
investigated. Retinal I/R injury caused a mild increase in the total
IkBa level, and a dramatic increase in the p-IkBa level. Oral
administration of curcumin significantly inhibited the I/R induced
phosphorylation of IkBa (Figure 6).
STAT (signal transducer and activator of transcription) is
another inflammatory regulating transcription factor family, in
which STAT1 and 3 are two members. The transcriptional
activation of STAT1/3 is regulated by their respective phosphor-
ylation levels. The expression levels of total and phosphorylated
STAT3 (p-Tyr705, p-Ser727) and STAT1 (p-Tyr701), as well as
JAK2 (the upstream kinase regulating the phosphorylation levels of
STAT1/3) were investigated one day after the injury. Our results
indicated that retinal I/R injury caused a mild, but significant,
increase in total STAT3 (1.6-fold), and dramatic increases in its
phosphorylation at sites p-Tyr705 (7.8-fold) and p-Ser727 (8.8-
fold) (Figure 7). Oral administration of 0.05% curcumin
significantly inhibited the injury-induced over-expression of p-
STAT3 (Tyr705), while showed no significant effects on the levels
of total STAT3 or p-STAT3 (Ser727). Retinal I/R injury also
caused dramatic increases in the levels of total STAT1 (3.6-fold)
and p-STAT1 (2.3-fold), but oral curcumin had no significant
effects on either (Figure 7). Neither injury nor curcumin pre-
treatment showed any effect on the expression level of JAK2
(Figure 7).
Figure 4. Curcumin partially inhibited retinal I/R-induced brn3a stained cell loss. (A) Representative pictures of brn3a stained retinal
sections 2 days after the injury (100 mm length per picture). (B) Number of brn3a stained cells was measured as described in Methods. Group
abbreviations are: C, non-injured eyes; I/R, I/R-injured eyes; I/R + Cur, I/R-injured eyes of animals treated with 0.05% curcumin 2 days before the injury.
(n=5–6 rats per group; *P,0.01 compared with non-injured retinas; **P,0.02 compared with I/R-injured retinas). The error bars represent standard
error of the mean.
doi:10.1371/journal.pone.0023194.g004
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inflammation and the immune system under multiple conditions.
It has been reported that ERK is one of kinases responsible for the
Ser727 phosphorylation of STAT3 [22]. Retinal I/R injury
significantly up-regulated ERK phosphorylation one day after the
injury, but 0.05% curcumin pre-treatment did not inhibit the
injury-induced ERK activation (Figure 8).
The mRNA levels of several proinflammatory chemokines and
cytokines also were investigated after retinal I/R injury. MCP-1 is
a chemokine involved in the inflammatory response via recruit-
ment of monocytes, memory T cells and dendritic cells to sites of
tissue injury and infection [23]. We found that retinal I/R injury
caused a 2.3-fold increase in the expression level of MCP-1, and
oral administration of curcumin significantly inhibited this injury-
induced over-expression of MCP-1 12 hours after the injury
(Figure 9). The mRNA levels of pro-inflammatory cytokines, such
as IL-1a, IL-1b, IL-6 and TNF-a, were significantly elevated
12 hours after the injury, but 0.05% curcumin pre-treatment did
not inhibit the injury-induced up-regulation of these mRNA (data
not shown).
Discussion
In the present study, curcumin, a natural phenolic compound,
was evaluated for its ability to inhibit neuronal and vascular
degeneration induced by I/R injury in retinas. Our results indicate
that pre-treatment with curcumin not only significantly inhibited
neurodegeneration, but also inhibited retinal capillary degenera-
tion (Figures 1 and 2). Interestingly, curcumin had a stronger
protective effect on the vasculature than on retinal ganglion cells,
and showed vascular protective effects even when administered
after neurodegeneration was ongoing (Figure 1), suggesting that
the vasoprotective effects of curcumin are independent of its
neuronal protective effect.
Although the elimination half-life is short and the bioavailability
is poor [24], curcumin has a variety of pharmacologic effects
including acts as a neuroprotective agent in several neurologic
Figure 5. Curcumin showed no effect on I/R induced glial cell
activation. (A) Representative Western blots of retinal GFAP expres-
sion level 12 hours (12hr), 1 day (1D), 2 days (2D), and 3 days (3D) after
retinal I/R injury (top). b-actin in the same samples (bottom) was used
as loading control. (B) Representative Western blot of GFAP and b-actin
levels in retinas (top) with densitometric quantitative results (bottom) 2
days after retinal I/R injury. (n=3–5 in each group; *P,0.05 compared
with non-injured retinas). The error bars represent standard error of the
mean. (C) Representative pictures of GFAP staining on retinal sections 2
days after retinal I/R injury (100 mm length per picture). Group
abbreviations are: C, non-injured eyes; I/R, retinal I/R-injured eyes; I/R
+ Cur, I/R-injured eyes of animals treated with 0.05% curcumin 2 days
before the injury.
doi:10.1371/journal.pone.0023194.g005
Figure 6. Curcumin inhibited the activation of the NF-kB
signaling pathway 2 days after retinal I/R injury. Representative
western blots of IKKa, IKKb, IKKc,I kBa, p-IkBa and b-actin expression
levels in retinas are shown (A) with densitometric quantitative results
(B). Group abbreviations are: C, non-injured eyes; I/R, retinal I/R-injured
eyes; I/R + Cur, I/R-injured eyes of animals treated with 0.05% curcumin
2 days before the injury. (n=3–4 in each group; *P,0.05 compared
with non-injured retinas; **P,0.05 compared with I/R-injured retinas).
The error bars represent standard error of the mean.
doi:10.1371/journal.pone.0023194.g006
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from dopaminergic neurotoxicity, apparently through the inhibi-
tion of c-Jun N-terminal kinase pathway [25], and it also protected
the brain from I/R-induced neuronal damage by increasing the
antioxidant system and decreasing oxidative stress [26,27].
Furthermore, electroretinography studies demonstrated that
curcumin significantly inhibited light-induced reductions in
scotopic and photopic b-wave amplitudes in light-induced retinal
degeneration, perhaps by inhibiting the activation of NF-kB and
the over-expression of inflammatory genes [14].
A large range of curcumin doses and routes of administration
have been used to treat neurodegenerative diseases in animal
models (reviewed in [11]). Curcumin in diets (160–5000 ppm) has
been shown to reduce amyloid and oxidative damage, and to
inhibit the pathology in a transgenic mouse model of Alzheimer’s
disease [28,29]. Dosages of curcumin comparable to those used
previously by others significantly inhibited I/R-induced neurode-
generation including cell loss in GCL in the present study. Even
though the brn3a staining and b-tubulin III western blot results
demonstrated that curcumin has protective effects on ganglion
Figure 7. Curcumin inhibited the activation of STAT3, but not STAT1 levels 1 day after retinal I/R injury. Representative Western blots
of total JAK2, total STAT1 and p-STAT1, total STAT3, p-STAT3 (Tyr705), p-STAT3 (Ser727) and b-actin show expression levels in retinas (A) with
densitometric quantitative results summarized in (B). Group abbreviations are: C, non-injured eyes; I/R, retinal I/R-injured eyes; I/R + Cur, I/R-injured
eyes of animals treated with 0.05% curcumin 2 days before the injury. (n=4–5 in each group; *P,0.02 compared with non-injured retinas; **P,0.01
compared with I/R-injured retinas). The error bars represent standard error of the mean.
doi:10.1371/journal.pone.0023194.g007
Figure 8. Curcumin showed no inhibitory effect on ERK
activation 1 day after retinal I/R injury. Representative western
blots of total ERK1/2, phosphorylated ERK1/2 and b-actin (A) with
densitometric quantitative results (B). Phosphorylation levels of ERK1/2
were reported relative to total ERK1/2 expression, and normalized to
the non-injured group. Group abbreviations are: C, non-injured eyes; I/
R, retinal I/R-injured eyes; I/R + Cur, I/R-injured eyes of animals treated
with 0.05% curcumin 2 days before the injury. (n=4–5 in each group;
*P,0.05 compared with non-injured retinas). The error bars represent
standard error of the mean.
doi:10.1371/journal.pone.0023194.g008
Figure 9. Curcumin inhibited retinal I/R induced up-regulation
of MCP-1 12 hours after I/R injury. Representative Western blots of
MCP-1 and b-actin expression levels in retinas (A) with densitometric
quantitative results (B). Group abbreviations are: C, non-injured eyes; I/
R, retinal I/R-injured eyes; I/R + Cur, I/R-injured eyes of animals treated
with 0.05% curcumin 2 days before the injury. (n=3–4 in each group;
*P,0.05 compared with non-injured retinas; **P,0.05 compared with I/
R-injured retinas). The error bars represent standard error of the mean.
doi:10.1371/journal.pone.0023194.g009
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other neuronal cells in retina. Further experiments are still
required to investigate the effects of curcumin on other cell types,
such as displaced amacrine cell that consists about 50% neurons in
the GCL [15].
NF-kB initiates transcription of many inflammatory genes, and
activation of this transcription factor can occur by either canonical
or non-canonical pathways. The canonical pathway of NF-kB
activation involves the phosphorylation of IkBa, an endogenous
inhibitory protein of NF-kB, by the kinase, IKKb. This
phosphorylation leads to IkBa degradation, translocation of NF-
kB/p65:p50 dimer to the nucleus, and subsequent activation of
gene transcription [30]. In the non-canonical pathway, the NF-
kB/RelB:p52 dimer is translocated into the nucleus through
activation of IKKa [31]. Our results suggest curcumin might
regulate both canonical and non-canonical ways of NF-kB
activation, since administration of the drug to retinal I/R injured
rats caused a modest up-regulation of IkBa and a dramatic down-
regulation of p-IkBa (both consistent with its inhibitory effect on
the canonical pathway), and inhibited IKKa expression (consistent
with inhibition of the non-canonical pathway).
STAT3 is another inflammatory transcription factor responsive
to cytokine signaling, such as the proinflammatory cytokine IL-6
[32]. Transcriptional activation of STAT3 involves its phosphor-
ylation at Tyr705, which leads to the cascade of STAT3
dimerization, nuclear translocation and gene transcription [32].
On the other hand, phosphorylation of STAT3 at Ser727
regulates energy metabolism in cells [33]. STAT3 phosphorylation
at the different sites is regulated by different kinases. In the present
study, the observation that curcumin showed no effect on the
phosphorylation levels of STAT3 at Ser727 (Figure 7) is consistent
with our finding that the dosage of curcumin used by us had no
effect on the activation of ERK (Figure 8). Our observation of
curcumin-mediated inhibition of STAT3 phosphorylation at
Tyr705 (Figure 7) is consistent with the previous report that
curcumin inhibits constitutive and IL-6 inducible STAT3
activation [34]. Our results suggest that curcumin inhibits the
STAT3 transcriptional activity via inhibition of Tyr705 phos-
phorylation, while having no effect on other cellular functions
(such as energy regulation) that are mainly controlled by Ser727
phosphorylation [33]. Apparently, not all kinases that responsible
for STAT3 phosphorylation can be regulated by curcumin.
Crosstalk between NF-kB and STAT3 has been found under
many conditions [35]. Both NF-kB and STAT3 are rapidly
activated in response to various stimuli including stresses and
cytokines, although they are regulated by entirely different
mechanisms. Once activated, NF-kB and STAT3 control the
transcription of multiple inflammatory, proliferative and immune
response genes, some of which even require the cooperation of
these two transcription factors [36,37].
MCP-1 is an inflammatory molecule [23] whose synthesis is
regulated by NF-kB and STAT3 signaling pathways [36]. The up-
regulation of MCP-1, which is responsible for the recruitment of
inflammatory cells infiltration in the retina, has been reported after
retinal I/R injury [3,38]. In the present study, curcumin
significantly inhibited the I/R-induced up-regulation of MCP-1
(Figure 9), consistent with its inhibitory effects on NF-kB and
STAT3 activation (Figures 6 and 7).
Glial cells are important retinal cell types that modulate
neuronal activity and affect the survival of neurons after various
insults [39,40]. Over-expression of GFAP is a recognized marker
of glial activation, but the exact function of GFAP activation in
retina remains unclear. Curcumin has been reported to down-
regulate the elevated mRNA levels of GFAP after spinal cord
injury [41], but showed no effect on retinal I/R-induced glial
activation at the dose used in the present study. One possible
explanation for this is that I/R induced GFAP overexpression in
retina might be activated by pathways different from those in
spinal cord injury.
In this study, we demonstrate that curcumin treatment results in
a partial, but significant, inhibition of neuronal and vascular
damage after I/R injury. Curcumin also inhibits multiple aspects
of inflammation that are activated by the I/R injury, raising a
possibility that inflammatory pathways might contribute to the
inhibition of retinal neurovascular damage by the drug. Since
neuronal and vascular damage are major elements in the
pathogenesis also of several other retinal diseases, curcumin may
thus serve as a promising candidate to inhibit such retinal
pathology.
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